Key facts
- Newton's Tree’s last known valuation is $10.8M (Mar 2025).
- It has raised $4.2M; the latest was Accelerator/Incubator in Apr 2025.
- Notable investors include Octopus Ventures, Texas Medical Center, Calm/Storm Ventures, The NHS Innovation Accelerator, ABHI US Accelerator — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Newton's Tree
- ·The full record, as it builds
Funding rounds
No funding rounds for Newton's Tree are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Newton's Tree
Developer of an artificial intelligence(AI) governance and deployment platform designed to help healthcare organizations adopt artificial intelligence safely, responsibly, and effectively in clinical practice. The company's platform offers a vendor-neutral marketplace, sandbox testing environment, workflow integration tools, and continuous performance monitoring, enabling hospitals and healthcare providers to evaluate, deploy, and manage AI applications with greater clinical safety, operational control, and long-term reliability.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 21
- Website
- newtonstree.ai/
- Ownership
- Privately Held (backing)
Newton's Tree doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Newton's Tree shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Newton's Tree in its N-PORT filings yet. We sweep new filings monthly.